Outset Medical, Inc.

Outset Medical, Inc. (OM) priced its initial public offering on Sep 16, 2020 at $27.00 per share, above its $22.00–$24.00 range, raising $241.7M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $1.11B. BofA Securities was lead-left underwriter, joined by Morgan Stanley, Goldman Sachs and Leerink Partners and others. Sidley Austin advised the company and Latham & Watkins advised the underwriters.

Outset Medical, Inc. is a medical technology company that makes the Tablo Hemodialysis System, designed to reduce the cost and complexity of dialysis. Tablo needs only an electrical outlet and tap water, with built-in water purification and on-demand dialysate production, for use in acute and home settings.

Status

IPO

Ticker

OM

Exchange

Nasdaq Global Select

Priced

Sep 16, 2020

IPO price

$27.00

Price range

$22.00–$24.00

Raised

$241.7M

Market cap at IPO price

$1.11B

First filed

Aug 21, 2020

Underwriters

BofA Securities, Morgan Stanley, Goldman Sachs, Leerink Partners and Stifel

Company counsel

Sidley Austin

Underwriters' counsel

Latham & Watkins

Sector

Healthcare

Country / state

CA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.